Key result
This review examines the relationship between central nervous system diseases, antidepressant and antipsychotic drugs, and their effects on blood coagulation, platelets, and fibrinolysis.
Why the study?
To examine the relationship between central nervous system diseases, medications used in their treatment, and the blood coagulation process.
Do antidepressant and antipsychotic drugs affect the blood coagulation process in patients with central nervous system diseases?
Do antidepressant and antipsychotic drugs affect the blood coagulation process in patients with central nervous system diseases?
Answers are grounded in this paper and cite their sources.
This review highlights the potential effects of antidepressant and antipsychotic drugs on the blood coagulation process, including impacts on platelets, vascular endothelium, plasma coagulation, and fibrinolysis.
The aim of this review was to examine the relationship between the occurrence of central nervous system (CNS) diseases, the medicines used in their treatment and the blood coagulation process. The paper mainly focuses on the effects of antidepressant and antipsychotic drugs. Special attention has been paid to the influence of drugs on platelets, the vascular endothelium, plasma coagulation and fibrinolysis, regarding coagulation.
No takes yet. Share an insight, caveat, or question.
Podsiedlik et al. (2019) conducted a review in Central nervous system diseases and haemostatic disorders. Antidepressant and antipsychotic drugs was evaluated on Effects on platelets, vascular endothelium, plasma coagulation and fibrinolysis. This review examines the relationship between central nervous system diseases, antidepressant and antipsychotic drugs, and their effects on blood coagulation, platelets, and fibrinolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: